興發集團(600141.SH):3月底完成800噸/年磷化劑工業化試驗裝置項目建設,目前產品訂單充足
格隆匯4月21日丨有投資者在投資者互動平台向興發集團(600141.SH)提問,“公司磷化劑項目進展如何?公司磷化劑產品與同行相比有什麼優勢?其他企業是否也會切入到磷化劑產品?”
興發集團回覆稱,公司2023年3月底完成800噸/年磷化劑工業化試驗裝置項目建設,目前產品訂單充足,市場價格約1萬美元/噸。公司計劃在明年上半年將產能擴大至5000噸/年。與同行以黃磷為原料相比,公司磷化劑以自有次磷酸鈉副產的磷化氫尾氣為原料,具有明顯的成本優勢和技術優勢。此外,由於磷化氫屬於劇毒氣體,同時也是易燃易爆氣體,屬於國家重點監管的危險化學品,監管要求嚴,技術門檻高,一般企業不會也很難切入到該產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.